News | News By Subject | News by Disease News By Date | Search News

Inflammation (general) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Novartis AG (NVS) Granted Three Breakthrough Badges for Ilaris     4/27/2016
Amgen (AMGN) Deal Brings Xencor $45M Up Front, Setup for $1.7B in Milestones     9/16/2015
EXCLUSIVE: Cancer Therapy Benefits Realized Long After FDA Approval, Study Author Tells BioSpace (DHX)     6/29/2015
Aquinox (AQXP)’s Bladder Pain Drug Fails to Meet Statistical Endpoint in Phase II Trial     6/25/2015
Galapagos (GLPG.BR) Ends Long-Running R&D Inflammation Pact With Janssen Pharmaceutica N.V.     3/17/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Dynavax Technologies Corporation (DVAX) Regains Full Rights To Investigational TLR 7/9 Inhibitor DV1179 Following Expiration Of Collaboration With GlaxoSmithKline (GSK)     12/1/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Novartis Pharmaceutical Corporation (NVS) AIN457 (secukinumab) Showed Significant Symptom Improvement In Two Pivotal Phase 3 ankylosing spondylitis Studies     11/17/2014
TxCell Achieves Positive Results For Col-Treg In A Model Of Autoimmune Uveitis     10/28/2014
Ablynx (ABLYF)'s Ant-Il-6R Nanobody Partnered With AbbVie (ABBV) Demonstrates A Bioavailability Of More Than 80% After Subcutaneous Injection     10/23/2014
Soligenix (SNGX) Awarded National Institute of Allergy And Infectious Diseases (NIAID) Contract Valued Up To $24.7 Million     9/19/2014
Innapharma: Completion Of Target Enrollment In The Phase 2 EffiKIR Trial     7/24/2014
Ablynx (ABLYF) Scores $840 Million Inflammatory Drug Pact With AbbVie (ABBV); Ablynx Stock Rises 24.73% at Market Close (September 23, 2013)     9/23/2013

News from Around the Web
Frequent Nut Consumption Associated With Less Inflammation, Brigham and Women's Hospital Study     8/3/2016
FDA Proposes Ban On Most Powdered Medical Gloves     3/22/2016
The Science Of Why Your Muscles Get Less Sore As You Stick With Your Gym Routine, Brigham Young University Study     2/9/2016
Inflammation Can Fan The Flames Of Depression, Rice University Study     12/21/2015
Inflammation May Bring On Depression Symptoms, Emory University School of Medicine Study     11/23/2015
Could A Pill Make Bacon As Beneficial As Fish Oil? University of Gothenburg Study     8/28/2015
If You Want To Reach 100, Keep Your Inflammation Levels Low, Newcastle University Study     8/10/2015
Drinking Coffee May Lower Inflammation, Diabetes Risk, Harokopio University     7/21/2015
Mothers Can Pass Traits To Offspring Through Bacteria's DNA, Washington University in St. Louis Study     2/23/2015
Yale University School Of Medicine Team Identifies Link Between Inflammation And Type 2 Diabetes     2/10/2015
Use Nature, Art, And Religion To Boost Your Body's Defense System, University of California, Berkeley (CAL) Study     2/6/2015
Personality And Health May Have A Genetic Link, University of Nottingham Study     12/12/2014
Novel Treatment To Decrease Craving In Alcoholics Identified, Université Catholique de Louvain Study     10/31/2014
Over-The-Counter Pain Med May Restore Immune Function In Old Age, Ohio State University Study     9/3/2014
Aspirin's Second Effect: Reduces Inflammation, University of California, San Diego (UCSD) Study     8/20/2014

Press Releases
Aclaris (ACRS) Announces Publication Of Data From Phase II Clinical Trial Of A-101 Topical Solution For Treatment Of Facial Seborrheic Keratosis     9/19/2017
Cardax Welcomes Cardiovascular Research Breakthrough     9/19/2017
CSL Behring Announces FDA Approval Of Privigen [Immune Globulin Intravenous (Human), 10% Liquid] For The Treatment Of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) In Adults     9/15/2017
XBiotech (XBIT) Announces Presentation Of Phase II Study Data Evaluating Mabp1 For The Treatment Of Hidradenitis Suppurativa     9/7/2017
Agragen Engineers Camelina To Produce A Biological Pharmaceutical For Treating Inflammatory Diseases To Dramatically Reduce The Costs For This Popular Drug     8/7/2017
Sandoz Canada Release: Sandoz Erelzi (Etanercept) Receives Positive Reimbursement Recommendation From Common Drug Review For Treatment Of Multiple Inflammatory Diseases     8/2/2017
Sirnaomics Leading siRNA Therapeutic Candidate, STP705, Granted Orphan Designation For The Treatment Of Primary Sclerosing Cholangitis (PSC)     8/1/2017
Complexa Raises $62 Million In Series C Financing To Test CXA-10 In Two Orphan Disease Proof-Of-Concept Trials     7/26/2017
Bioniz Reports Top-Line Phase I Clinical Study Results For BNZ-1, A Novel Multi-Cytokine Inhibitor     7/19/2017
FDA Accepts CSL Behring's Supplemental Biologics License Application For Hizentra Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Indication     7/19/2017
Amgen (AMGN) And Array BioPharma (ARRY) Announce Preclinical License And Collaboration Agreement In Inflammation     7/18/2017
Neuraltus Pharmaceuticals, Inc. Announces Completion Of Enrollment In Confirmatory Phase II Study Of NP001 In ALS Patients With Systemic Inflammation     7/12/2017
Nektar Therapeutics (NKTR) Presents New Preclinical Data For NKTR-358, A First-In-Class Regulatory T Cell Stimulator, At 13th World Congress Of Inflammation In London     7/10/2017
Heptares And Peptidream Enter Strategic Collaboration To Discover, Develop And Commercialise Novel Therapeutics In Inflammatory Disease     6/29/2017
Aldeyra (ALDX) To Present Novel Data On The Anti-Inflammatory Mechanism And Activity Of ADX-102 At The World Congress On Inflammation 2017 Annual Meeting     6/19/2017

//-->